VaramirStart free · no cardSign in
TGTX as of Nov 3 · 02:57 ET
TGTXNasdaqPharmaceutical Preparations

TG Therapeutics, Inc. · Brief

Next report

6 days

Nov 9 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 8≥ implied
avg implied
±12.2%
avg realized
±11.2%
Nov 4 '24±15.3%▼−9.44%×0.62
Mar 3 '25±11.7%▲+14.39%×1.23
May 5 '25±13.6%▼−13.26%×0.98
Aug 4 '25±12.5%▼−17.99%×1.44
Q3 FY25±14.9%▼−3.13%×0.21
Q1 FY26±9.3%▲+4.18%×0.45
May 6 '26±8.7%▲+16.26%×1.87
Q2 FY26±11.4%▼−11.26%×0.99
quarterimplied−20%0+20%realized×
Q2 FY26±11.4%▼−11.26%×0.99
May '26±8.7%▲+16.26%×1.87
Q1 FY26±9.3%▲+4.18%×0.45
Q3 FY25±14.9%▼−3.13%×0.21
Aug '25±12.5%▼−17.99%×1.44
May '25±13.6%▼−13.26%×0.98
2 older reports
Mar '25±11.7%▲+14.39%×1.23
Nov '24±15.3%▼−9.44%×0.62
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2 of 3

7disclosed supplier and customer ties in SEC filingsSEC filings
433managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

11 of 24largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
5 of 8recent reports where the move came in under the options implied rangeEarnings history
AI captions · Sep 27 '26once per report · top 2 per case

Linked exposure

TGTX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 19impliedImplied move: ±13.3% into Nov 2 earnings (Oct 19 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.